Tackling Respiratory Viruses

Preparing for Respiratory Virus Season

It’s not just flu season anymore. While viruses can spread all year, the end of summer through March marks the time of year when we can expect to see flu, COVID-19, and RSV circulating at higher rates in Illinois. Explore key information, resources, and guidance on flu and COVID-19 vaccines and Respiratory Syncytial Virus (RSV) prevention tools for your clinical workflow while improving outreach. Get access to engaging toolkits, handouts, reports, and social media content below to help keep children in Illinois safe from these respiratory viruses.

Important Note: Helping parents and guardians understand the benefits of vaccinations and the other tools we have to combat these viruses is essential and means the most coming from you. This information is dedicated to supporting you in getting families back in for vaccinations and following up with your most at-risk patients.

Explore Resources On:

Flu

RSV

COVID-19

Social Media Outreach

Flu Vaccine

Resources & Outreach Materials

The AAP recommends that everyone age 6 months and older get a flu vaccine. ICAAP’s 2023-2024 Flu Vaccination Toolkit provides resources for both patients and providers, including the most up-to-date clinical guidance, strategies for increasing flu vaccine uptake in your practice, and social media images with prepared captions.

Download ICAAP’s 2023 Flu Toolkit

Flu Resources:

Influenza Vaccine Products for the 2023-2024 Influenza Season (Immunize.org)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season (MMWR)

Influenza Pre-booking

Standing Orders (flu vaccine) for teens and children

Screening Checklist for Contraindication to Inactivated Injectable Influenza Vaccination

Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination

AAP Policy Statement

AAP Technical Report

RSV Prevention Treatment

Resources & Outreach Materials

While RSV is not new, we have seen large spikes in recent RSV seasons, resulting in overburdened pediatric hospital systems. This year there are new RSV prevention tools, which are a vaccine for older adults, and Nirsevimab (Beyfortus), a long-acting antibody treatment for babies and infants, in addition to Palivizumab (SYNAGIS). Make sure you know what options are available to your patients as we navigate this year’s RSV season.

RSV Resources:

AAP RSV Prevention Page

AAP RSV Administration Guide

Nirsevimab Information for Parents/Guardians (English)

Nirsevimab Information for Parents/Guardians (Spanish)

Nirsevimab Summary for Providers

RSV Products Visual Guide

Beyfortus Immunization Information Statement (IIS)

Palivizumab Prescribing Information

Nirsevimab (Beyfortus) – FAQs for Healthcare Professionals (Pediatric Pandemic Network)

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices (MMWR)

WRAP-EM Pediatric Surge Playbook

COVID-19 Vaccine

Resources & Outreach Materials

COVID-19 remains a threat to the safety and well-being of all children in Illinois. Get the latest updates on vaccine advancements, implementation, and outreach strategies to help protect your patients and their loved ones.

Clinical Resources for Fall 2023/2024 Vaccines

Dosing and Scheduling Charts

Storage and Handling

Comirnaty (2023-2024 Formula)

Spikevax (2023-2024 Formula)

Moderna COVID-19 Vaccine (2023-2024 Formula)

Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula)

June 15, 2023 Meeting of the VRBPAC

September 12, 2023 Meeting of the ACIP

COVID-19 Vaccine Commercialization FAQ

Patient Facing Materials

Facts on Vaccines Infographic Poster (English)